Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study

N Engl J Med. 2021 Aug 5;385(6):570-571. doi: 10.1056/NEJMc2107920. Epub 2021 Jun 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • COVID-19 Vaccines / adverse effects*
  • Female
  • Humans
  • Middle Aged
  • Risk Factors
  • South Africa / epidemiology
  • Thromboembolism / epidemiology
  • Thromboembolism / etiology*

Substances

  • COVID-19 Vaccines
  • Ad26.COV2.S vaccine